| 4U0I: reference: Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients., Garner AP, Gozgit JM, Anjum R, Vodala S, Schrock A, Zhou T, Serrano C, Eilers G, Zhu M, Ketzer J, Wardwell S, Ning Y, Song Y, Kohlmann A, Wang F, Clackson T, Heinrich MC, Fletcher JA, Bauer S, Rivera VM, Clin Cancer Res. 2014 Sep 19. pii: clincanres.1397.2014. PMID: 25239608 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).